With Biotech stocks running into a speed-bump in the past couple sessions including today, we have seen some liquidations in the levered long LABU (Direxion Daily S&P Biotech Bull 3X, Expense Ratio 1.09%).
Category: NYSE:LABU
Direxion Investments Launches Four Leveraged ETFs For Active Traders
Direxion Investments announces the launch of four new daily leveraged exchange-traded funds (ETFs).